OBJECTIVE: To evaluate the utility of a modified frailty index as an indicator of postoperative mortality in patients undergoing tracheostomy. STUDY DESIGN: Case series with chart review. SETTING: Tertiary care veterans hospital. SUBJECTS AND METHODS: A chart review was conducted of consecutive tracheostomies performed between April 2007 and September 2012. A modified frailty index consisting of 11 items based on the Revised Minimum Data Set Mortality Rating Index (MMRI-R) was retrospectively applied using the patient's status immediately prior to tracheostomy. The resultant 6-month calculated mortality risk was compared with both the Veterans Health Administration Surgical Quality Improvement Program's (VASQIP) 30-day calculated mortality and actual mortality. RESULTS: One hundred consecutive tracheostomies were analyzed. No patients were excluded. Sixty-nine patients died within the study period, with 1-, 6-, and 12-month mortality rates of 25%, 43%, and 59%, respectively. The average calculated 6-month mortality risk using the modified frailty index was 40.5% for nonsurvivors compared with 25.4% for survivors (P = .001). Both the VASQIP calculator and modified frailty index differentiated mortality risks between patients without head and neck cancer who survived less than 6 months versus those who survived longer than 6 months (P = .006 and .01). However, neither the VASQIP nor the modified frailty index differentiated mortality risks for head and neck cancer patients who survived less than 6 months versus greater than 6 months (P = .94 and .26). CONCLUSION: A modified frailty index identifies patients without head and neck cancer at high risk of postoperative mortality after tracheostomy.
OBJECTIVE: To evaluate the utility of a modified frailty index as an indicator of postoperative mortality in patients undergoing tracheostomy. STUDY DESIGN: Case series with chart review. SETTING: Tertiary care veterans hospital. SUBJECTS AND METHODS: A chart review was conducted of consecutive tracheostomies performed between April 2007 and September 2012. A modified frailty index consisting of 11 items based on the Revised Minimum Data Set Mortality Rating Index (MMRI-R) was retrospectively applied using the patient's status immediately prior to tracheostomy. The resultant 6-month calculated mortality risk was compared with both the Veterans Health Administration Surgical Quality Improvement Program's (VASQIP) 30-day calculated mortality and actual mortality. RESULTS: One hundred consecutive tracheostomies were analyzed. No patients were excluded. Sixty-nine patients died within the study period, with 1-, 6-, and 12-month mortality rates of 25%, 43%, and 59%, respectively. The average calculated 6-month mortality risk using the modified frailty index was 40.5% for nonsurvivors compared with 25.4% for survivors (P = .001). Both the VASQIP calculator and modified frailty index differentiated mortality risks between patients without head and neck cancer who survived less than 6 months versus those who survived longer than 6 months (P = .006 and .01). However, neither the VASQIP nor the modified frailty index differentiated mortality risks for head and neck cancerpatients who survived less than 6 months versus greater than 6 months (P = .94 and .26). CONCLUSION: A modified frailty index identifies patients without head and neck cancer at high risk of postoperative mortality after tracheostomy.
Authors: Tyler J Loftus; Elisha M Collins; Camille G Dessaigne; Amber N Himmler; Alicia M Mohr; Ryan M Thomas; Charles E Hobson; George A Sarosi; William J Zingarelli Journal: Surg Endosc Date: 2017-04-13 Impact factor: 4.584
Authors: Daniel E Hall; Shipra Arya; Kendra K Schmid; Mark A Carlson; Pierre Lavedan; Travis L Bailey; Georgia Purviance; Tammy Bockman; Thomas G Lynch; Jason M Johanning Journal: JAMA Surg Date: 2017-03-01 Impact factor: 14.766
Authors: Sudhir Isharwal; Jason M Johanning; Jennifer G Dwyer; Kendra K Schimid; Chad A LaGrange Journal: World J Urol Date: 2016-05-12 Impact factor: 4.226
Authors: Katherine F Ernst; Daniel E Hall; Kendra K Schmid; Georgia Seever; Pierre Lavedan; Thomas G Lynch; Jason Michael Johanning Journal: JAMA Surg Date: 2014-11 Impact factor: 14.766
Authors: Kristen M C Malecki; Julie K Andersen; Andrew M Geller; G Jean Harry; Chandra L Jackson; Katherine A James; Gary W Miller; Mary Ann Ottinger Journal: Front Aging Neurosci Date: 2022-02-21 Impact factor: 5.750
Authors: M E C van Winden; S Garcovich; K Peris; G Colloca; E M G J de Jong; M E Hamaker; P C M van de Kerkhof; S F K Lubeek Journal: J Eur Acad Dermatol Venereol Date: 2020-07-01 Impact factor: 9.228